Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06709534 · ClinicalTrials.gov registry record · NA
An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors
A NA study of Malignant Female Reproductive System Neoplasm, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 4
- Study locations
NCT06709534 is a NA study of Malignant Female Reproductive System Neoplasm that is actively recruiting participants, run by Emory University. The registered enrollment target is 40 participants, below the 402-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (90% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT06709534, a NA study of Malignant Female Reproductive System Neoplasm, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 4
- Study locations
Study Summary
This clinical trial tests an individualized online home-based exercise program in gynecologic cancer survivors and its impact on gut microbiome (the bacteria and microorganisms that live in the digestive system) and symptoms such as pain, fatigue, sleep disturbance, depression, and cognitive impairment. These symptoms can significantly reduce the quality of life (QoL) and survival rate in this cancer population. Thus, promoting physical activity among cancer survivors may help mitigate these severe symptoms. Using online platforms such as Zoom can help participants access an individualized exercise program that meets their specific needs to engage in physical activity and decrease their symptom burden. Home-based exercise, by providing self-chosen time and location and low costs, can address some barriers to physical activity for cancer survivors. An individualized online home-based exercise program may be feasible, and may improve symptoms and quality of life in gynecologic cancer survivors.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- OTHER Exercise Intervention
- OTHER Functional Assessment
- OTHER Medical Device Usage and Evaluation
- OTHER Supportive Care
Study Locations (4)
Georgia
- Grady Health System - Atlanta
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital/Winship Cancer Institute - Atlanta
- Emory Decatur Hospital - Decatur
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2027-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06709534
The ClinicalTrials.gov registry entry for NCT06709534 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 402-participant average among 18 other Malignant Female Reproductive System Neoplasm trials with a reported enrollment target (90% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Malignant Female Reproductive System Neoplasm appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire Administration is the first listed.
NCT06709534 reports 4 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT06709534 about?
NCT06709534 is a clinical study titled "An Individualized Online Home-Based Exercise Program for Improving Symptoms in Gynecologic Cancer Survivors". This clinical trial tests an individualized online home-based exercise program in gynecologic cancer survivors and its impact on gut microbiome (the bacteria and microorganisms that live in the digestive system) and symptoms such as pain, fatigue, sleep disturbance, depression, and cognitive impairm...
What is the current status of trial NCT06709534?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-09-01. Estimated completion is 2027-07-30.
What conditions does trial NCT06709534 study?
This clinical trial studies the following conditions: Malignant Female Reproductive System Neoplasm.
What interventions are being tested in trial NCT06709534?
The interventions under investigation include: Questionnaire Administration (OTHER), Exercise Intervention (OTHER), Functional Assessment (OTHER), Medical Device Usage and Evaluation (OTHER), Supportive Care (OTHER).
Who is sponsoring clinical trial NCT06709534?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06709534 being conducted?
This trial has 4 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Female Reproductive System Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cancer Genetic Testing in Ethnic Populations
RECRUITING · NA
-
Self-Hypnosis for the Enhanced Recovery After Surgery in Patients With Gynecologic Cancer
ACTIVE NOT RECRUITING · NA
-
Home Base Telemonitoring in Gastrointestinal, Genitourinary, or Gynecologic Cancer Patients Undergoing Abdominal Surgery
ACTIVE NOT RECRUITING · NA
-
e-Health Intervention (Day-by-Day) for the Management of Fear of Progression in Women With Stage III or IV Gynecologic Cancer: A Pilot Study
ACTIVE NOT RECRUITING · NA
-
Conquer Fear SUPPORT Intervention in Supporting Patients With Stage III-IV Lung or Gynecologic Cancer
COMPLETED · NA
-
EHealth Mindful Movement and Breathing in Improving Outcomes in Participants Undergoing Gynecologic Surgery
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.